Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice

[11] Vanover KE(1996)Effects of dopamine D2-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition CNS Drugs 6 237-256

[12] Borenstein P(1990)Amisulpride: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia Pharmacopsychiatry 23 125-130

[13] Champion C(2014)Amisulpride versus haloperidol in treatment of schizophrenic patients—results of a double-blind study Rev Neurosci 25 401-415

[14] Cujo P(2014)Selective agonists for serotonin 7(5HT7) receptor and their applications in preclinical models: an overview Eur J Pharmacol 734 15-22

[15] Gekière F(1988)(S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics Ann Clin Psychiatry 3 298-305

[16] Olivenstein C(1981)Pharmacokinetics and metabolism of amisulpride Psychopharmacology 73 363-371

[17] Kramarz P(1991)Inter-animal olfactory cues in operant drug discrimination procedures in rats Eur J Pharmacol 202 191-199

[18] Boyajian CL(2008)Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue Behav Pharmacol 19 153-159

[19] Leslie FM(2004)Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity Psychopharmacology 171 212-222

[20] Burstein ES(1999)Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine Pharmacol Biochem Behav 64 193-201

[11] Vanover KE(1996)Effects of dopamine D2-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition CNS Drugs 6 237-256

[12] Borenstein P(1990)Amisulpride: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia Pharmacopsychiatry 23 125-130

[13] Champion C(2014)Amisulpride versus haloperidol in treatment of schizophrenic patients—results of a double-blind study Rev Neurosci 25 401-415

[14] Cujo P(2014)Selective agonists for serotonin 7(5HT7) receptor and their applications in preclinical models: an overview Eur J Pharmacol 734 15-22

[15] Gekière F(1988)(S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics Ann Clin Psychiatry 3 298-305

[16] Olivenstein C(1981)Pharmacokinetics and metabolism of amisulpride Psychopharmacology 73 363-371

[17] Kramarz P(1991)Inter-animal olfactory cues in operant drug discrimination procedures in rats Eur J Pharmacol 202 191-199

[18] Boyajian CL(2008)Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue Behav Pharmacol 19 153-159

[19] Leslie FM(2004)Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity Psychopharmacology 171 212-222

[20] Burstein ES(1999)Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine Pharmacol Biochem Behav 64 193-201